539136
Protease Inhibitor Cocktail IV
liquid, for the inhibition of serine proteases, cysteine proteases, aspartic proteases and metalloproteases. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
Synonym(s):
Protease inhibitor cocktail
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352200
NACRES:
NA.54
Recommended Products
product name
Protease Inhibitor Cocktail Set IV, The Protease Inhibitor Cocktail Set IV controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
form
liquid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
shipped in
wet ice
storage temp.
−20°C
General description
A cocktail of four protease inhibitors with broad specificity for the inhibition of aspartic-, cysteine-, metallo-, and serine-proteases. Recommended for fungal and yeast cell extracts. Each vial contains 100 mM AEBSF, HCl (Cat. No. 101500), 1.5 mM E-64 (Cat. No. 324890), 2 mM Pepstatin A (Cat. No. 516481), and 500 mM 1,10-Phenanthroline (Cat. No. 516705). Supplied with a data sheet. Note: 1 set = 5 x 1 ml.
The Protease Inhibitor Cocktail Set IV controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
Specificity
Inhibits a broad spectrum of serine proteases, cysteine proteases, aspartic proteases, and metalloproteases.
Application
Protease Inhibitor Cocktail Set IV, is a cocktail of four protease inhibitors with broad specificity for the aspartic, cysteine, metallo & serine-proteases. Recommended for fungal & yeast cells.
Biochem/physiol Actions
Primary Target
aspartic-, cysteine-, metallo-, and serine-proteases
aspartic-, cysteine-, metallo-, and serine-proteases
Product does not compete with ATP.
Warning
Toxicity: Toxic (F)
Physical form
In 1 ml DMSO.
Reconstitution
Protease Inhibitor Cocktail Set IV can be used at a 1:100-1:1000 dilution for most applications.
Other Notes
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Irrit. 2
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Flash Point(F)
188.6 °F - Information refers to the main ingredient.
Flash Point(C)
87 °C - Information refers to the main ingredient.
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Joseph V Geisberg et al.
Current protocols in molecular biology, 128(1), e101-e101 (2019-09-11)
Here we describe CLIP-READS, a technique that combines elements of crosslinking and immunoprecipitation (CLIP) and 3' region extraction and deep sequencing (READS), to provide a genome-wide map of mRNA 3' isoform binding by a given messenger ribonucleoprotein (mRNP). In CLIP-READS
Chaperones directly and efficiently disperse stress-triggered biomolecular condensates.
Yoo, et al.
Molecular Cell, 82, 741-755 (2023)
Haneul Yoo et al.
STAR protocols, 3(2), 101409-101409 (2022-05-24)
Heat stress triggers a specific set of proteins in budding yeast to form solid-like biomolecular condensates, which are dispersed by molecular chaperones. Here, we describe a protocol to study the kinetics of chaperone-facilitated condensate dispersal using biochemical reconstitution and fluorescence anisotropy.
Micaela Boiero Sanders et al.
The EMBO journal, 41(5), e107982-e107982 (2022-02-19)
A paradox of eukaryotic cells is that while some species assemble a complex actin cytoskeleton from a single ortholog, other species utilize a greater diversity of actin isoforms. The physiological consequences of using different actin isoforms, and the molecular mechanisms
Zhouying Wu et al.
Frontiers in molecular biosciences, 8, 707295-707295 (2021-09-14)
The inhibitor of CDK4/6 has been clinically used for treating certain types of cancer which are characterized by G0/G1 acceleration induced by the CDK4/6-RB1 pathway. On the contrary, the cell cycle-related molecules are abnormal in over 50% of the patients
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service